Subcellular imaging of biochemical processes within human retina

Information

  • Research Project
  • 7909691
  • ApplicationId
    7909691
  • Core Project Number
    R43EY020715
  • Full Project Number
    1R43EY020715-01
  • Serial Number
    20715
  • FOA Number
    PA-09-080
  • Sub Project Id
  • Project Start Date
    4/1/2010 - 14 years ago
  • Project End Date
    12/31/2010 - 13 years ago
  • Program Officer Name
    WUJEK, JEROME R
  • Budget Start Date
    4/1/2010 - 14 years ago
  • Budget End Date
    12/31/2010 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/16/2010 - 14 years ago
Organizations

Subcellular imaging of biochemical processes within human retina

DESCRIPTION (provided by applicant): Our long-term goal is to develop a clinical instrument, the 2-photon ophthalmoscope, for non-invasive, high-resolution and repetitive imaging of biochemical processes within the human retina. Such an instrument will have tremendous potential for early detection of age and disease related changes in the eye, long before pathological manifestations of retinal disease become obvious. This real-time retinal imaging instrument will also be critical for rapid evaluation of various pharmacological agents used to treat retinal pathologies. The method has the great advantage of imaging endogenous retinoid fluorophores in their native state without the need for additional staining. In Phase I, we seek to answer whether two-photon excitation based imaging can track age related changes in the retina and then whether a 2-photon ophthalmoscope, with the ultimate goal of clinical instrument can be made. We are proposing three specific aims: (1) Determine whether two-photon excitation imaging can be used to monitor age related changes in human retina;(2) Image the eye of a living monkey to determine the feasibility of two-photon adaptive optics ophthalmoscope system for non-invasive, in vivo imaging of human retinal pigment epithelium cells;and (3) Determine if the size and cost of the instrument could be reduced by replacing the Ti:Sapphire modelocked laser with a femtosecond fiber laser to validate commercialization plans. Once these aims are fulfilled, in Phase 2 we will use the derived data to adapt the two-photon adaptive optics ophthalmoscope for imaging human eyes in vivo and characterize two-photon fluorescence in eyes affected by retina diseases. In addition, the use of the fiber laser and micro-electro- mechanical systems deformable mirror technology, in adaptive optics design, promises to reduce the cost and allow the physical footprint of the instrument to be kept small, greatly aiding potential commercialization. PUBLIC HEALTH RELEVANCE: We seek to develop a novel instrument for noninvasive imaging of the back of the eye with sub-cellular resolution. The instrument will visualize the age or disease related changes in the biochemical processes within human retina, specifically retinoid cycle. Our goal is to further understanding of the biochemistry of vision to allow for rapid evaluation of various pharmacological interventions to prevent retinal degeneration and other pathologies at the early stages, before the retina degenerates and vision is irreparably damaged.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R43
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    188126
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:188126\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    POLGENIX, INC.
  • Organization Department
  • Organization DUNS
    785024089
  • Organization City
    CLEVELAND
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    441063079
  • Organization District
    UNITED STATES